For following the competition: what moved in each program, several studies read as one move.
- humanized bispecific antibody neutralizing both sclerostin AND DICKKOPF-1 (AGA-2115)
- humanized bispecific antibody neutralizing both sclerostin AND DICKKOPF-1 (AGA-2115)
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Osteogenesis Imperfecta to watchlistEvery Monday by email · turn it off any timePro · free during the beta